A gene-based avian influenza vaccine in poultry

Poultry Science

Volumn 88, Issue 4, 2009, Pages 860-866

  Rao, S S ^a   Styles, D ^b   Kong, W ^a   Andrews, C ^a   Gorres, J P ^a   Nabel, G J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNITED STATES DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Deoxyribonucleic acid; Gene based; Influenza; Poultry; Vaccine

Indexed keywords

AVES; BACTERIA (MICROORGANISMS); GALLUS GALLUS; INFLUENZA A VIRUS; INFLUENZAVIRUS A; MUS; REPLICATION DEFECTIVE VIRUSES;

DNA VACCINE; INFLUENZA VACCINE;

ANIMAL; ARTICLE; AVIAN INFLUENZA; GENE VECTOR; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; POULTRY;

ANIMALS; GENETIC VECTORS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY; VACCINES, DNA;

EID: 65549120673     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2008-00360     Document Type: Article

References (58)

1. Ahringer, J. 2006. Reverse genetics. WormBook doi/10.1895/worm- book.1.47.1. http://www.wormbook.org Accessed July 2008.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
3. Becker, A. L. 2004. USDA funds avian flu vaccine bank for poultry. http://www.cidrapbusiness.net/cidrap/content/influenza/avian-flu/news/nov0504vaccine.html Accessed July 2008.
4. Bergman, P. J. 2007. Anticancer vaccines. Vet. Clin. North Am. Small Anim. Pract. 37:1111-1119.
5. Bernstein, D. I., K. M. Edwards, C. L. Dekker, R. Belshe, H. K. Talbot, I. L. Graham, D. L. Noah, F. He, and H. Hill. 2008. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J. Infect. Dis. 197:667-675.
6. Bublot, M., N. Pritchard, D. E. Swayne, P. Selleck, K. Karaca, D. L. Suarez, J. C. Audonnet, and T. R. Mickle. 2006. Development and use of fowlpox vectored vaccines for avian influenza. Ann. N. Y. Acad. Sci 1081:193-201.
7. Capua, I., and D. J. Alexander. 2004. Avian influenza: Recent developments. Avian Pathol. 33:393-404.
8. Capua, I., and D. J. Alexander. 2006. The challenge of avian influenza to the veterinary community. Avian Pathol. 35:189-205.
9. Cinatl, J. Jr., M. Michaelis, and H. W. Doerr. 2007a. The threat of avian influenza A (H5N1). Part IV: Development of vaccines. Med. Microbiol. Immunol. (Berl.) 196:213-225.
10. Cinatl, J. Jr., M. Michaelis, and H. W. Doerr. 2007b. The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. Med. Microbiol. Immunol. (Berl.) 196:181-190.
11. Crawford, P. C., E. J. Dubovi, W. L. Castleman, I. Stephenson, E. P. Gibbs, L. Chen, C. Smith, R. C. Hill, P. Ferro, J. Pompey, R. A. Bright, M. J. Medina, C. M. Johnson, C. W. Olsen, N. J. Cox, A. I. Klimov, J. M. Katz, and R. O. Donis. 2005. Transmission of equine influenza virus to dogs. Science 310:482-485.
12. Dauphin, G., and S. Zientara. 2007. West Nile virus: Recent trends in diagnosis and vaccine development. Vaccine 25:5563-5576.
13. Food and Agriculture Organization of the United Nations. 2006. Should wild birds now be considered a permanent reservoir of the virus? FAO AIDE News 40:1-11. http://www.fao.org/docs/eims/upload/209858/AVIbull040.pdf Accessed July 2008.
14. Fouchier, R. A., P. M. Schneeberger, F. W. Rozendaal, J. M. Broekman, S. A. Kemink, V. Munster, T. Kuiken, G. F. Rimmelzwaan, M. Schutten, G. J. Van Doornum, G. Koch, A. Bosman, M. Koopmans, and A. D. Osterhaus. 2004. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl. Acad. Sci. USA 101:1356-1361.
15. Ge, J., G. Deng, Z. Wen, G. Tian, Y. Wang, J. Shi, X. Wang, Y. Li, S. Hu, Y. Jiang, C. Yang, K. Yu, Z. Bu, and H. Chen. 2007. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homolo- gous and heterologous H5N1 avian influenza viruses. J. Virol. 81:150-158.
16. Gray, G. C. 2008. Pandemic influenza planning: Shouldn't swine and poultry workers be included? 2008 Poult. Sci. Assoc. Keynote Symp. Poult. Sci. Assoc., Savoy, IL. (Abstr.)
17. Hargis, B. M., S. L. Layton, D. R. Kapczynski, K. Cole, M. M. Cox, Y. M. Kwon, L. R. Berghman, K. Liljebjelke, and W. J. Bottje. 2008. Development and evaluation of a potential universal Salmonella-vectored avian influenza vaccine. 2008 Poult. Sci. Assoc. Keynote Symp. Poult. Sci. Assoc., Savoy, IL. (Abstr.)
18. Holl, S., and J. Redding. 2005. USDA issues license for West Nile virus DNA vaccine for horses. http://www.aphis.usda.gov/lpa/news/2005/07/wnvdna_vs.html Accessed July 2008.
19. Ito, T., J. N. Couceiro, S. Kelm, L. G. Baum, S. Krauss, M. R. Castrucci, I. Donatelli, H. Kida, J. C. Paulson, R. G. Webster, and Y. Kawaoka. 1998. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72:7367-7373.
20. Karaca, K., D. E. Swayne, D. Grosenbaugh, M. Bublot, A. Robles, E. Spackman, and R. Nordgren. 2005. Immunogenicity of fowl-pox virus expressing the avian influenza virus H5 gene (TRO- VAC AIV-H5) in cats. Clin. Diagn. Lab. Immunol. 12:1340-1342.
21. Kuiken, T., E. C. Holmes, J. McCauley, G. F. Rimmelzwaan, C. S. Williams, and B. T. Grenfell. 2006. Host species barriers to influenza virus infections. Science 312:394-397.
22. Leroux-Roels, I., A. Borkowski, T. Vanwolleghem, M. Drame, F. Clement, E. Hons, J. M. Devaster, and G. Leroux-Roels. 2007. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: A randomised controlled trial. Lancet 370:580-589.
23. Liu, M. A., B. Wahren, and G. B. Karlsson Hedestam. 2006. DNA vaccines: Recent developments and future possibilities. Hum. Gene Ther. 17:1051-1061.
24. Lo, C. Y., Z. Wu, J. A. Misplon, G. E. Price, C. Pappas, W. P. Kong, T. M. Tumpey, and S. L. Epstein. 2008. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: Cold adapted vaccine versus DNA prime-adenovirus boost strategies. Vaccine 26:2062-2072.
25. Lorenzen, N., and S. E. LaPatra. 2005. DNA vaccines for aquacultured fish. Rev. Sci. Tech. 24:201-213.
26. Marangon, S., M. Cecchinato, and I. Capua. 2008. Use of vaccination in avian influenza control and eradication. Zoonoses Public Health 55:65-72.
27. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.
28. Mcleod, A., N. Morgan, A. Prakash, J. Hinrichs, and Food and Agriculture Organization of the United Nations. 2005. Economic and social impacts of avian influenza. http://www.fao.org/avianflu/documents/Economic-and-social-impacts-of-avian-influenza-Geneva.pdf Accessed August 2008.
29. Merial. 2007. Merial's new vaccine treats deadly cancer in dogs. http://us.merial.com/merial_corporate/news/press_releases/03-26-2007_melanoma_consumer.asp Accessed July 2008.
30. MIT Canada Inc. 2008. Agro-Jet. http://www.mitcanada.ca/products/products.html Accessed July 2008.
31. Myers, T. J., and A. P. Morgan. 1997. Policy and guidance for licensure of avian influenza vaccines in the United States. Pages 373-378 in Proceedings of the 4th International Symposium on Avian Influenza, Athens, GA. D. E. Swayne. and R. D. Slemons, ed. Georgia Center for Continuing Education, Athens.
32. Paglia, P., E. Medina, I. Arioli, C. A. Guzman, and M. P. Colombo. 1998. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92:3172-3176.
33. Parsa, S., and B. Pfeifer. 2007. Engineering bacterial vectors for delivery of genes and proteins to antigen-presenting cells. Mol. Pharm. 4:4-17.
34. Peiris, J. S., M. D. de Jong, and Y. Guan. 2007. Avian influenza virus (H5N1): A threat to human health. Clin. Microbiol. Rev. 20:243-267.
35. Poulet, H., J. Minke, M. C. Pardo, V. Juillard, B. Nordgren, and J. C. Audonnet. 2007. Development and registration of recombinant veterinary vaccines. The example of the canarypox vector plat- form. Vaccine 25:5606-5612.
36. Qiao, C., G. Tian, Y. Jiang, Y. Li, J. Shi, K. Yu, and H. Chen. 2006. Vaccines developed for H5 highly pathogenic avian influenza in China. Ann. N. Y. Acad. Sci 1081:182-192.
37. Quinlivan, M., D. Zamarin, A. Garcia-Sastre, A. Cullinane, T. Chambers, and P. Palese. 2005. Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79:8431-8439.
38. Rao, S., L. J. DeTolla, D. Perez, D. Smith, W. P. Kong, T. Tumpey, A. Garcia-Sastre, C. J. Wei, Z. Y. Yang, and G. J. Nabel. 2008a. A gene-based vaccine: Multivalent HA DNA vaccination confers long-term protection in mice and chicken. 2008 Poult. Sci. Assoc. Keynote Symp. Poult. Sci. Assoc., Savoy, IL. (Abstr.)
39. Rao, S., W. Kong, C. Wei, Z. Yang, M. Nason, D. Styles, L. DeTolla, E. Sorrell, H. Song, H. Wan, G. Ramirez-Nieto, D. Perez, and G. Nabel. 2008b. Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS One 3:e2432.
40. Richt, J. A., P. Lekcharoensuk, K. M. Lager, A. L. Vincent, C. M. Loiacono, B. H. Janke, W. H. Wu, K. J. Yoon, R. J. Webby, A. Solorzano, and A. Garcia-Sastre. 2006. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modi- fied live-virus vaccine. J. Virol. 80:11009-11018.
41. Shata, M. T., L. Stevceva, S. Agwale, G. K. Lewis, and D. M. Hone. 2000. Recent advances with recombinant bacterial vaccine vectors. Mol. Med. Today 6:66-71.
42. Song, J. M., Y. J. Lee, O. M. Jeong, H. M. Kang, H. R. Kim, J. H. Kwon, J. H. Kim, B. L. Seong, and Y. J. Kim. 2008. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea. Vet. Micro- biol. 130:268-276.
43. Steensels, M., S. Van Borm, B. Lambrecht, J. De Vriese, F. X. Le Gros, M. Bublot, and T. van den Berg. 2007. Efficacy of an inac-tivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Dis. 51(Suppl.):325-331.
44. Subbarao, K., H. Chen, D. Swayne, L. Mingay, E. Fodor, G. Brownlee, X. Xu, X. Lu, J. Katz, N. Cox, and Y. Matsuoka. 2003. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305:192-200.
45. Subbarao, K., and J. M. Katz. 2004. Influenza vaccines generated by reverse genetics. Curr. Top. Microbiol. Immunol. 283:313-342.
46. Swayne, D. E. 2008. Avian influenza vaccines and therapies for poultry. Comp. Immunol. Microbiol. Infect. Dis. doi:doi:10.1016/j. cimid.2008.01.006.
47. Taubenberger, J. K., D. M. Morens, and A. S. Fauci. 2007. The next influenza pandemic: Can it be predicted? J. Am. Med. Assoc. 297:2025-2027.
48. Toro, H., D. C. Tang, D. L. Suarez, J. Zhang, and Z. Shi. 2008. Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine 26:2640-2646.
49. Tosh, P. K., and G. A. Poland. 2008. Emerging vaccines for influenza. Expert Opin. Emerg. Drugs 13:21-40.
50. van den Berg, T., B. Lambrecht, S. Marche, M. Steensels, B. S. Van, and M. Bublot. 2008. Influenza vaccines and vaccination strategies in birds. Comp. Immunol. Microbiol. Infect. Dis. 31:121-165.
51. Van Reeth, K. 2007. Avian and swine influenza viruses: Our current understanding of the zoonotic risk. Vet. Res. 38:243-260.
52. Vana, G. and K. M. Westover. 2008. Origin of the 1918 Spanish influenza virus: A comparative genomic analysis. Mol. Phylogenet. Evol. 47:1100-1110.
53. Veits, J., D. Wiesner, W. Fuchs, B. Hoffmann, H. Granzow, E. Starick, E. Mundt, H. Schirrmeier, T. Mebatsion, T. C. Mettenleiter, and A. Romer-Oberdorfer. 2006. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against New- castle disease and avian influenza. Proc. Natl. Acad. Sci. USA 103:8197-8202.
54. Vical Inc. 2005. Vical announces marketing approval of DNA vaccine for salmon. Goliath, The Gale Group, Cengage Learning, Farmington Hills, MI. http://goliath.ecnext.com/coms2/summary_0199-4481412_ITM Accessed August 2008.
55. Webby, R. J., and M. R. Sandbulte. 2008. Influenza vaccines. Front. Biosci. 13:4912-4924.
56. Webster, R. G., R. J. Webby, E. Hoffmann, J. Rodenberg, M. Kumar, H. J. Chu, P. Seiler, S. Krauss, and T. Songserm. 2006. The immunogenicity and efficacy against H5N1 challenge of reverse genetics-derived H5N3 influenza vaccine in ducks and chickens. Virology 351:303-311.
57. World Health Organization. 2005. Avian influenza: Assessing the pandemic threat. http://www.who.int/csr/disease/influenza/H5N1-9reduit.pdf Accessed June 2008.
58. Wright, P. F. 2008. Vaccine preparedness-Are we ready for the next influenza pandemic? N. Engl. J. Med. 358:2540-2543.